Institute of Experimental Haematology and Transfusion Medicine, University Clinic Bonn, Bonn, Germany.
Vivantes Klinikum im Friedrichshain, Klinik für Innere Medizin Angiologie und Hämostaseologie, Berlin, Germany.
Hamostaseologie. 2021 Jun;41(3):184-189. doi: 10.1055/a-1469-7481. Epub 2021 Apr 1.
The COVID-19 pandemic is an ongoing global healthcare crisis. Based on reports of atypically located thromboses following vaccination with the AstraZeneca COVID-19 vaccine, the Society of Thrombosis and Haemostasis Research (GTH) has issued guidance statements on the recognition, diagnosis, and treatment of this rare complication. It shares pathophysiological features with heparin-induced thrombocytopenia (HIT) and is referred to as vaccine-induced prothrombotic immune thrombocytopenia (VIPIT).
COVID-19 大流行是一场持续的全球医疗保健危机。基于接种阿斯利康 COVID-19 疫苗后出现异常位置血栓的报告，血栓与止血学会（GTH）发布了关于识别、诊断和治疗这种罕见并发症的指南声明。它与肝素诱导的血小板减少症（HIT）具有相同的病理生理学特征，被称为疫苗诱导的促血栓形成免疫性血小板减少症（VIPIT）。
